[Eli Lilly and Company](https://www.lillyinvestigatorresearch.com)

February 15, 2026 (Proposal submission deadline)

Award amount and duration vary by project; support may include study drug and/or financial funding as outlined in the RFP.

Supports investigator-initiated clinical research on lebrikizumab’s impact on post-inflammatory dyspigmentation in moderate to severe atopic dermatitis using the PDCA-Derm™ scale.

--- ## Description Eli Lilly and Company’s Competitive Clinical Research Grant provides funding and/or study drug supply for investigator-initiated studies in response to specific Requests for Proposals (RFPs). For this RFP, the focus is on research evaluating how lebrikizumab impacts post-inflammatory dyspigmentation, as measured by the PDCA-Derm™ scale, in patients with moderate to severe atopic dermatitis. The grant is designed to support independent researchers in the design, conduct, and regulatory sponsorship of their studies, with Lilly providing oversight and support as described in the RFP. --- ## Due Dates - February 15, 2026: Proposal submission deadline --- ## Funding Amount - Funding amount and duration are not fixed and depend on the scope and requirements of the proposed study. - Support may include provision of lebrikizumab study drug and/or financial funding as detailed in the RFP and proposal. - No minimum or maximum award amount is specified; budgets should be justified according to the research plan. --- ## Eligibility - Open to external investigators and research teams at academic, clinical, or research institutions. - Proposals must be investigator-initiated and independently designed, conducted, and sponsored by the applicant institution. - No explicit career stage or institutional restrictions are listed, but proposals must align with Lilly’s research priorities and the specific RFP. - International applicants are eligible if their country is listed in the application form; if not, select "Other" and specify your country. --- ## Application Process - Review the details of the RFP on the [Lilly Investigator Research Competitive Grants page](https://www.lillyinvestigatorresearch.com/competitive-grants#request-for-proposals-how-does-lebrikizumab-impact-post-inflammatory-dyspigmenta). - Download and complete the proposal form linked in the RFP. - Submit the completed proposal by email to [CCRG@lilly.com](mailto:CCRG@lilly.com) before the deadline. - The application process involves: - Submission of a brief study concept (if not directly submitting a full proposal). - If the concept is deemed in scope, a full proposal and protocol are requested. - Study readiness activities (contracting, budgeting, ethics, and drug shipment) follow approval. - Proposals are reviewed by Lilly’s global medical/scientific committees, and may involve external reviewers. --- ## Additional Information - The principal investigator and their institution are responsible for study design, conduct, and regulatory compliance. - Lilly provides oversight, study drug, and/or financial support as specified in the RFP and agreement. - The focus for this cycle is on lebrikizumab’s effect on post-inflammatory dyspigmentation using validated clinical scales. - Only proposals relevant to the current RFP topic will be considered for this deadline. --- ## External Links - [Lilly Investigator Research Competitive Grants page](https://www.lillyinvestigatorresearch.com/competitive-grants#request-for-proposals-how-does-lebrikizumab-impact-post-inflammatory-dyspigmenta) - [Lilly Investigator Initiated Research homepage](https://www.lillyinvestigatorresearch.com) - [Frequently Asked Questions](https://www.lillyinvestigatorresearch.com/FAQs) - [Contact Us](https://www.lillyinvestigatorresearch.com/contact-us) --- ## Contact Information | Type | Details | |-----------------|--------------------------------------------------------------| | Program Email | [CCRG@lilly.com](mailto:CCRG@lilly.com) | | General Contact | [Lilly Investigator Research Contact Form](https://www.lillyinvestigatorresearch.com/contact-us) | ---

Competitive Clinical Research Grant

Sign in to see full grant listing